Cell Mechanics in Cancer: Integrating Mechanotransduction Pathways Within the Tumor Microenvironment
Journal of Cellular Physiology · 2026
DOI: 10.1002/jcp.70184 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, 2026. Verfasst von Merve Sevgi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Yıldız Technical University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Mechanotransduction, Cellular, Tumor Microenvironment, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 221 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Arastirma Kurumu, Scientific and Technological Research Council of Turkiye (TUBİTAK).
Abstract (Originalsprache)
Single‐cell mechanical properties such as stiffness, elasticity, and viscosity, are crucial in governing biological processes like migration, proliferation, and differentiation. In cancer, the mechanical properties of cells undergo significant alterations, which contribute to tumor growth, metastasis, and resistance to therapy. This review focuses on cancer cell stiffness and explores how its regulation is disrupted by the complex interplay among cytoskeletal remodeling, nuclear mechanics, and extracellular matrix (ECM) interactions. Cancer‐associated fibroblasts (CAFs) and ECM composition within the tumor microenvironment (TME) modulate cellular mechanics via mechanotransduction pathways involving Yes‐associated protein/transcriptional coactivator with PDZ‐binding motif (YAP/TAZ) and integrin‐focal adhesion kinase (FAK) signaling. Increasing evidence supports cell stiffness as a promising diagnostic and prognostic biomarker, as well as a predictor of treatment response. Therefore, advanced techniques for measuring cell stiffness such as atomic force microscopy (AFM), Brillouin microscopy, and acousto‐holography are evaluated with a focus on their potential clinical applicability. However, translation into routine oncology practice remains limited by technical variability, lack of standardized protocols, and the need for large‐scale clinical validation. This review highlights the potential of integrating biomechanical markers into clinical workflows as a means to advance cancer diagnostics and enable more personalized therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Bioengineering, Yıldız Technical University, Istanbul, Turkey.
- Department of Mechatronics Engineering, Yıldız Technical University, Istanbul, Turkey.
- Oncology Institute, Dokuz Eylül University, Izmir, Turkey.
- Department of Biotechnology, Institute of Science, Istanbul University, Istanbul, Turkey.
- Artificial Intelligence Research and Application Center, Istinye University, Istanbul, Turkey.
ORCID-Profile: Yağmur Işık
Förderung
- Türkiye Bilimsel ve Teknolojik Arastirma Kurumu
- Scientific and Technological Research Council of Turkiye (TUBİTAK)
Zitieren
APA
Sevgi, M., Işık, Y., Karaca, C., Çağlar, E., Abdioğlu, H. B., Zendel, F., Başbınar, Y., & Üvet, H. (2026). Cell Mechanics in Cancer: Integrating Mechanotransduction Pathways Within the Tumor Microenvironment. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70184
Vancouver
Sevgi M, Işık Y, Karaca C, Çağlar E, Abdioğlu HB, Zendel F, et al. Cell Mechanics in Cancer: Integrating Mechanotransduction Pathways Within the Tumor Microenvironment. Journal of Cellular Physiology. 2026. doi:10.1002/jcp.70184
BibTeX
@article{Sevgi2026,
author = {Sevgi, Merve and Işık, Yağmur and Karaca, Caner and Çağlar, Esmahan and Abdioğlu, Hasan Berkay and Zendel, Ferican and Başbınar, Yasemin and Üvet, Hüseyin},
title = {Cell Mechanics in Cancer: Integrating Mechanotransduction Pathways Within the Tumor Microenvironment},
journal = {Journal of Cellular Physiology},
year = {2026},
doi = {10.1002/jcp.70184}
}
EUVIMED